Skip to main content
OpenTrials
Completed

NCT Number: NCT04013828

Treatment Decision-making in Patients With Recurrent High-grade Glioma

This qualitative study explores the lived experience of high-grade glioma patients and their close relatives at time of recurrence. With focus on the decision-making about treatment and care..

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Copenhagen University Hospital; Rigshospitalet, Copenhagen, Denmark

Loading trial locations.

About this study

High-Grade Glioma is a life-threatening disease that can cause the patient substantial physical, mentally and psychosocially impairment. The life expectancy is short, and a majority of patients experience recurrence of tumour growth. At time of recurrence, the treatment possibilities can include surgery, oncological treatment and/or palliative care.

In this situation the patients and their close relatives need to make a difficult balancing between benefits and trade offs.

Little is known about how the patients and their close relatives experience the recurrence and the decision-making process.

The objective of this study is therefore to explore the perspectives, experiences and needs in patients and their close relatives in relation to the decision-making process at time of recurrence.

Data will be generated through semi-structured interviews. Interviews will be analysed and interpreted using a Ricoeur inspired method of qualitative analysis.

The study is part of a larger PhD-study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient is offered surgical treatment (after an assesment done by the multidisciplinary team)
  • Able to speak and understand danish
  • Able to participate in an interview
  • Able to give informed concent for participation

Exclusion criteria

  • Patients with severe cognitive impairment which prohibits them from either giving informed concent or participating in interview.
  • Relatives are excluded if the patient do not give concent for the participation of relatives

Treatment and study plan

Primary outcomes

  1. Experiences of patients and relatives

    Time frame: Interviews are performed 2-6 weeks after the decision-making

    How patients and their close relatives experience the decision-making process

  2. Involvement preferences

    Time frame: Interviews are performed 2-6 weeks after the decision-making

    The preferences of patients and relatives for being involved in the decision-making.

Sponsors and collaborators

Lead sponsor

Odense University Hospital

Other

Collaborators

  • Danish Cancer Society
  • Novo Nordisk A/S
  • Region of Southern Denmark
  • Rigshospitalet, Denmark

Registry information

Official study title

Recurrent High-grade Glioma: Experiences of Patients and Their Close Relatives During the Treatment Decision-making Process.

Important dates

Study start
2019
Primary completion
2020
Study completion
2022
First posted
Jul 10, 2019
Registry last updated
Apr 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.